ClinicalTrials.govpublic full text
Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy
follicular lymphoma, follicular non-hodgkin´s lymphoma, autologous effector lymphocytes
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 390909
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.